Cargando…

Human Intestinal Defensin 5 Inhibits SARS-CoV-2 Invasion by Cloaking ACE2

Detalles Bibliográficos
Autores principales:	Wang, Cheng, Wang, Shaobo, Li, Daixi, Wei, Dong-Qing, Zhao, Jinghong, Wang, Junping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the AGA Institute 2020
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211585/ https://www.ncbi.nlm.nih.gov/pubmed/32437749 http://dx.doi.org/10.1053/j.gastro.2020.05.015

Ejemplares similares

Cloaking the ACE2 receptor with salivary cationic proteins inhibits SARS-CoV-2 entry
por: Yoshizato, Katsutoshi, et al.
Publicado: (2022)

Discovery of a Natural Product with Potent Efficacy Against SARS-CoV-2 by Drug Screening
por: Li, Daixi, et al.
Publicado: (2021)

Soluble ACE2 in SARS-CoV-2 infection
por: Allison, Susan
Publicado: (2021)

HD5 and LL-37 Inhibit SARS-CoV and SARS-CoV-2 Binding to Human ACE2 by Molecular Simulation
por: Li, Daixi, et al.
Publicado: (2021)

Correction to: HD5 and LL‑37 Inhibit SARS‑CoV and SARS‑CoV‑2 Binding to Human ACE2 by Molecular Simulation
por: Li, Daixi, et al.
Publicado: (2021)

Age, Inflammation, and Disease Location Are Critical Determinants of Intestinal Expression of SARS-CoV-2 Receptor ACE2 and TMPRSS2 in Inflammatory Bowel Disease
por: Nowak, Jan Krzysztof, et al.
Publicado: (2020)

Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry
por: Xu, Chuan, et al.
Publicado: (2021)

Equivalence between positive and negative refractive index materials in electrostatic cloaks
por: Li, Xingcai, et al.
Publicado: (2021)

Defensin 5 for prevention of SARS-CoV-2 invasion and Covid-19 disease
por: Niv, Yaron
Publicado: (2020)

ACE2-Targeting antibody suppresses SARS-CoV-2 Omicron and Delta variants
por: Ou, Jianxia, et al.
Publicado: (2022)

Differential Pathogenesis of SARS-CoV-2 Variants of Concern in Human ACE2-Expressing Mice
por: Natekar, Janhavi Prasad, et al.
Publicado: (2022)

Antcins from Antrodia cinnamomea and Antrodia salmonea Inhibit Angiotensin-Converting Enzyme 2 (ACE2) in Epithelial Cells: Can Be Potential Candidates for the Development of SARS-CoV-2 Prophylactic Agents
por: Senthil Kumar, K. J., et al.
Publicado: (2021)

A novel biparatopic hybrid antibody-ACE2 fusion that blocks SARS-CoV-2 infection: implications for therapy
por: Miao, Xiaoniu, et al.
Publicado: (2020)

Exosomes cloak the virion to transmit Enterovirus 71 non-lytically
por: Gu, Jiaqi, et al.
Publicado: (2019)

Highly conserved binding region of ACE2 as a receptor for SARS-CoV-2 between humans and mammals
por: Hayashi, Takuma, et al.
Publicado: (2020)

Glycyrrhizin Inhibits SARS-CoV-2 Entry into Cells by Targeting ACE2
por: He, Ming-Feng, et al.
Publicado: (2022)

ACE2 is not induced by interferon
por: Saffern, Miriam
Publicado: (2020)

Screened antipsychotic drugs inhibit SARS-CoV-2 binding with ACE2 in vitro
por: Lu, Jiayu, et al.
Publicado: (2021)

Prolonged Protective Immunity Induced by Mild SARS-CoV-2 Infection of K18-hACE2 Mice
por: Bar-On, Liat, et al.
Publicado: (2022)

Screening of Selected Stingless Bee Honey Varieties for ACE2-Spike Protein-Binding Inhibition Activity: A Potential Preventive Medicine Against SARS-Cov-2 Infection
por: Arung, Enos Tangke, et al.
Publicado: (2022)

Dexamethasone inhibits SARS-CoV-2 spike pseudotyped virus viropexis by binding to ACE2
por: Zhang, Yongjing, et al.
Publicado: (2021)

ACE-2, TMPRSS2, and Neuropilin-1 Receptor Expression on Human Brain Astrocytes and Pericytes and SARS-CoV-2 Infection Kinetics
por: Malik, Johid Reza, et al.
Publicado: (2023)

Folic acid restricts SARS-CoV-2 invasion by methylating ACE2
por: Zhang, Yuanzhou, et al.
Publicado: (2022)

Azelastine inhibits viropexis of SARS-CoV-2 spike pseudovirus by binding to SARS-CoV-2 entry receptor ACE2
por: Ge, Shuai, et al.
Publicado: (2021)

Cloaked similarity between HIV-1 and SARS-CoV suggests an anti-SARS strategy
por: Kliger, Yossef, et al.
Publicado: (2003)

Inhibition of SARS-CoV-2 Infection by Human Defensin HNP1 and Retrocyclin RC-101
por: Kudryashova, Elena, et al.
Publicado: (2022)

Effective protection of ZF2001 against the SARS-CoV-2 Delta variant in lethal K18-hACE2 mice
por: Bian, Lianlian, et al.
Publicado: (2022)

BNT162b2 Vaccine Encoding the SARS-CoV-2 P2 S Protects Transgenic hACE2 Mice against COVID-19
por: Ji, Rui-Ru, et al.
Publicado: (2021)

Amantadine Inhibits SARS-CoV-2 In Vitro
por: Fink, Klaus, et al.
Publicado: (2021)

ACE2 interaction with cytoplasmic PDZ protein enhances SARS-CoV-2 invasion
por: Zhang, Qiangmin, et al.
Publicado: (2021)

SARS-CoV-2 receptor ACE2 gene expression in small intestine correlates with age
por: Vuille-dit-Bille, Raphael N., et al.
Publicado: (2020)

The role of nicotinic receptors in SARS-CoV-2 receptor ACE2 expression in intestinal epithelia
por: ten Hove, Anne S., et al.
Publicado: (2020)

Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor
por: Yang, Jinsung, et al.
Publicado: (2020)

A novel hACE2 knock-in mouse model recapitulates pulmonary and intestinal SARS-CoV-2 infection
por: Zhou, Xiaoyang, et al.
Publicado: (2023)

Defensins: Therapeutic molecules with potential to treat SARS-CoV-2 infection
por: Banu, Sarena, et al.
Publicado: (2022)

The flexibility of ACE2 in the context of SARS-CoV-2 infection
por: Barros, E. P., et al.
Publicado: (2020)

The flexibility of ACE2 in the context of SARS-CoV-2 infection
por: Barros, Emilia P., et al.
Publicado: (2021)

ACE2-independent infection of T lymphocytes by SARS-CoV-2
por: Shen, Xu-Rui, et al.
Publicado: (2022)

Binding of SARS-COV-2 (COVID-19) and SARS-COV to human ACE2: Identifying binding sites and consequences on ACE2 stiffness
por: Faisal, H.M. Nasrullah, et al.
Publicado: (2021)

Cross-species recognition of SARS-CoV-2 to bat ACE2
por: Liu, Kefang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gjufdh5knk6mtdug6uj5ns4e5l